Gut Derived Metabolite, Trimethylamine N oxide (TMAO) in Cardio Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics Gut microbe derived metabolite trimethylamine N oxide activates PERK to drive fibrogenic mesenchymal differentiation: iScience The Carnitine butyrobetaine trimethylamine N oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis Atherosclerosis L Carnitine ((R) Carnitine) Co factor for oxidation MedChemExpress Identification of TMAO producer phenotype and hostdietgut dysbiosis by carnitine challenge test in human and germ free mice Gut PDF] Trimethylamine N Oxide, the Microbiome, and Heart and Kidney Disease. Semantic Scholar